Abstract
Background Scar size is critical to left ventricular (LV) remodeling and adverse outcomes following myocardial infarction (MI). Late Gadolinium-enhancement (LGE) in cardiac magnetic resonance imaging is the gold standard for assessing MI size. Texture-based probability mapping (TPM) is a novel machine learning-based analysis of LGE images. This proof-of-concept study investigates the potential clinical implications of temporal changes in TPM during the first year following an acute revascularized MI.
Methods 41 patients with first-time acute ST-elevation MI were included in this study. All patients had a single-vessel disease and were successfully revascularized by primary percutaneous coronary intervention. LGE images were obtained two days, one week, two months, and one year post-MI. MI size by TPM was compared with manual LGE-based MI calculation, LV remodeling, and biomarkers.
Results TPM showed a significant increase in infarct size from the second month through the first year (p<0.01). MI size estimated by TPM at all different time points demonstrated strong correlations with peak Troponin T levels. At one week, TPM assessment correlated positively with maximum C-reactive protein (r=0.54, p<0.01), and at two months, TPM positively correlated with N-Terminal Pro Brain Natriuretic Peptide.
Conclusion This proof-of-concept study suggests that TPM may provide additional information to conventional LGE-based MI analysis of scar formation, LV remodeling, and biomarkers following an acute revascularized MI.
Highlights
Texture-based probability mapping (TPM) was used to analyze consecutive cardiac magnetic resonance images acquired during the first year after ST-elevation myocardial infarction (STEMI).
TPM size was related to biomarkers of inflammation, myocardial injury and stress.
TPM is a step toward automatic image processing.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by Helse Vest grant no. 912296
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Regional Ethics Committee at the University of Bergen and was conducted according to the Declaration of Helsinki principles. All patients gave informed consent before their inclusion in the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵† Leik Woie passed away 25.07.21
Data Availability
The data that support the findings of this study are available on request from the corresponding author, [V.F]
List of abbreviations
- CVD
- cardiovascular disease
- MI
- Myocardial infarction
- STEMI
- ST-elevation myocardial infarction
- MVO
- microvascular obstruction
- TPM
- Texture-based probability mapping
- SI
- Signal intensity
- CMR
- Cardiac magnetic resonance imaging
- LGE-CMR
- late gadolinium-enhanced cardiac magnetic resonance imaging
- PCI
- percutaneous coronary intervention.
- LV
- Left ventricular
- LVEF
- Left ventricular ejection fraction
- LVEDVi
- Left ventricular end-diastolic volume index
- LVESVi
- Left ventricular end-systolic volume index
- eGFR
- estimated glomerular filtration rate
- hs-CRP
- high-sensitivity C-reactive protein
- NT-proBNP
- N-terminal pro-B-type natriuretic peptide
- TnT
- Cardiac troponin-T